Advertisement

January 17, 2011

Covidien Launches Next-Generation EverFlex+ Peripheral Stent System in Europe

January 18, 2011—Covidien (Mansfield, MA) announced the European launch of the EverFlex+ nitinol self-expanding peripheral stent system for the treatment of peripheral arterial disease.

According to the company, the EverFlex+ is intended to treat the superficial femoral artery (SFA) and proximal popliteal lesions. The device is designed to reduce the risk of fracture when elongated, improving clinical outcomes. The next-generation system offers the radial strength and flexibility of the current EverFlex system, with additional durability in a highly flexible platform, representing a significant advance in nitinol self-expanding stent technology. The EverFlex was launched worldwide in March 2006 for treating peripheral arterial disease and stenting for the SFA.

Advertisement


January 18, 2011

FDA Approves Cook Medical's Formula Renal Stents, REFORM Data Presented at ISET

January 18, 2011

FDA Approves Cook Medical's Formula Renal Stents, REFORM Data Presented at ISET


)